Head and Neck Cancer Stage III
3 clinical trials · Condition
◉ Watch Head and Neck Cancer Stage III
| Record | Firm | Date |
|---|---|---|
| Virtual Rehabilitation for Cancer Survivors (NCT05898789) | University Health Network, Toronto | 2023-07-07 |
| Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer (NCT03993353) | University of California, San Diego | 2020-04-07 |
| IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma (NCT03795610) | Assuntina G. Sacco, MD | 2020-03-06 |
Track Head and Neck Cancer Stage III automatically
Every clearance here is in the API, with alerts when new ones post.